SCHEMBL4040136

SCHEMBL4040136

c1cnc2[nH]c(CC3CCCC3)nc2n1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AAK1 Q2M2I8 1/20 0.43
PBK Q96KB5 1/20 0.40
PDE9A O76083 5/20 0.40
CCNB2 O95067 3/20 0.40
CDK1 P06493 3/20 0.40
CCNB1 P14635 3/20 0.40
GSK3A P49840 3/20 0.40
GSK3B P49841 3/20 0.40
CCNB3 Q8WWL7 3/20 0.40
UTS2R Q9UKP6 2/20 0.38
ADORA2A P29274 2/20 0.35
ADORA2B P29275 2/20 0.35
ADORA1 P30542 1/20 0.35
DGAT2 Q96PD7 1/20 0.35
METAP2 P50579 1/20 0.35
METAP1 P53582 1/20 0.35
PDE1C Q14123 1/20 0.34
HTR3A P46098 1/20 0.33
HRH4 Q9H3N8 1/20 0.33
IDO1 P14902 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4051351 0.98 PDE9A (0.42) AAK1PBKPDE9ACCNB2CDK1
SCHEMBL4048041 0.97 PBK (0.40) AAK1PBKPDE9ACCNB2CDK1
SCHEMBL4047661 0.93 PBK (0.42) AAK1PBKPDE9ACCNB2CDK1
SCHEMBL4055775 0.84 LMNA (0.36) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL4056218 0.83 LMNA (0.39) CCNB2CDK1CCNB1GSK3AGSK3B
SCHEMBL4046851 0.81 LMNA (0.34) PBKCCNB2CDK1CCNB1GSK3A
SCHEMBL4046172 0.77 METAP2 (0.35) PBKCCNB2CDK1CCNB1GSK3A
SCHEMBL4046994 0.71 ADORA1 (0.42) CDK1CCNB1GSK3AGSK3BADORA2A
SCHEMBL4054581 0.70 ADORA1 (0.40) PBKADORA2AADORA2BADORA1METAP2
SCHEMBL6791015 0.69 DGAT2 (0.42) AAK1PDE9AGSK3BUTS2RADORA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009029592-A1 HETEROBICYCLIC-SUBSTITUTED QUINOLONES USEFUL AS NITRIC OXIDE SYNTHASE INHIBITORS KALYPSYS, INC. (US) 2009-03-05 WO disclosed